Sponsor:
National Institutes of Health
UI Contact:
Updated Date:
Dec 8, 2020
The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices and funding opportunities:
Policy Notices
- Reminder to AHRQ Grantees that FY2016 Funds will Expire on September 30, 2021
Agency for Healthcare Research and Quality
- REMINDER - Expiring Funds Alert to AHRQ Grant Recipients who Received Multi-Year Funded Awards
Agency for Healthcare Research and Quality
- Updated Instructions on Interim Reporting and Carryover for RADx-UP Recipients
National Institutes of Health
General Notices
- NICHD Data and Safety Monitoring Guidelines for Extramural Clinical Trials and Clinical Research
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Notice of Changes to Funding Opportunities
- Notice to Extend NCCIH's PA-18-323, "Fundamental Science Research on Mind and Body Approaches (R01 Clinical Trial Optional)"
National Center for Complementary and Integrative Health
- Notice to Extend NCCIH's PA-18-322, "Funding Opportunity Title Fundamental Science Research on Mind and Body Approaches (R21 Clinical Trial Optional)"
National Center for Complementary and Integrative Health
- Notice of NIDDK Participation in PAR-20-238, Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
National Institute of Diabetes and Digestive and Kidney Diseases
- Notice of NICHD Participation on PA-20-200 "NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed)"
Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Notice of NICHD Participation on PA-20-194 "NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Required)"
Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Notice of NICHD Participation on PA-20-195 "NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed)"
Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Notice to Extend Expiration Date for PAR-19-133 "Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 - Clinical Trial Required)"
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Notices of Intent to Publish
- Notice of Intent to Publish a Funding Opportunity Announcement for Transformative Nucleic Acid Sequencing Technology Innovation and Early Development (R21)
National Human Genome Research Institute
- Notice of Intent to Publish a Funding Opportunity Announcement for Transformative Nucleic Acid Sequencing Technology Innovation and Early Development (R43/R44)
National Human Genome Research Institute
- Notice of Intent to Publish a Funding Opportunity Announcement for Transformative Nucleic Acid Sequencing Technology Innovation and Early Development (R01)
National Human Genome Research Institute
Notices of Special Interest
- Notice of Special Interest: Advances in Research for the Treatment, Services, and Recovery of Alcohol Use Disorder
National Institute on Alcohol Abuse and Alcoholism
- Notice of Special Interest: Kidney Precision Medicine Technology Development and Translation
National Institute of Diabetes and Digestive and Kidney Diseases
- Notice of Special Interest (NOSI): High-throughput Molecular and Cellular Phenotyping
National Human Genome Research Institute
- Notice of Special Interest (NOSI): Advancing Genomic Technology Development for Research and Clinical Application
National Human Genome Research Institute
Funding Opportunities
- NEI Institutional Mentored Physician Scientist Award (K12 Clinical Trial Optional)
National Eye Institute
- NHLBI Program Project Applications (P01 Clinical Trials Optional)
National Heart, Lung, and Blood Institute
- Limited Competition: Small Grant Program for ORIP Special Emphasis Research Career Award (SERCA) K01 Recipients (R03 Clinical Trials Not Allowed)
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
- Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21 Clinical Trial Optional)
National Cancer Institute
- Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)
National Cancer Institute
- Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
- Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
National Cancer Institute
- Revision Applications to Support the Application of Informatics Technology for Cancer Research (R01 Clinical Trials Optional)
- Revision Applications to Support the Application of Informatics Technology for Cancer Research (U01 Clinical Trials Optional)
- Revision Applications to Support the Application of Informatics Technology for Cancer Research (U24 Clinical Trial Optional)
National Cancer Institute
- Summer Institute for Research Education in Biostatistics and Data Science (R25 Clinical Trial Not Allowed)
National Heart, Lung, and Blood Institute
National Institute of Allergy and Infectious Diseases
Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at dsp@uiowa.edu or 335-2123, or email Carrie Damon at carolyn-damon@uiowa.edu or Dave Myers at dave-myers@uiowa.edu or Lynn Hudachek at lynn-hudachek @uiowa.edu